Zobrazeno 1 - 10
of 47
pro vyhledávání: '"C. William Helm"'
Publikováno v:
Surgery for Ovarian Cancer ISBN: 9780429054433
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be051afe6e7e33441148d42daea6b2b4
https://doi.org/10.1201/9780429054433-14
https://doi.org/10.1201/9780429054433-14
Autor:
Nichola C Garbett, Michael L Merchant, C William Helm, Alfred B Jenson, Jon B Klein, Jonathan B Chaires
Publikováno v:
PLoS ONE, Vol 9, Iss 1, p e84710 (2014)
Improved methods for the accurate identification of both the presence and severity of cervical intraepithelial neoplasia (CIN) and extent of spread of invasive carcinomas of the cervix (IC) are needed. Differential scanning calorimetry (DSC) has rece
Externí odkaz:
https://doaj.org/article/09cf011b9a9d40928773b730e7dea6fe
Autor:
Nicolò Bizzarri, Asima Mukhopadhyay, Jaydip Bhaumik, Subir Sinha, C. William Helm, Melissa Bradbury
Publikováno v:
International Journal of Gynecological Cancer. 28:293-301
In advanced epithelial ovarian cancer (AOC), lesser sac (LS) metastasis particularly to the supragastric LS (SGLS) may be overlooked, resulting in unrecognized residual disease. We aimed to identify the frequency, distribution, and predictors of LS m
Publikováno v:
Gynecologic Oncology. 144:363-368
Objective Many studies have examined the relationship between worry and cancer screening. Due to methodological inconsistencies, results of these studies have varied and few conclusions can be made when generalizing across studies. The purpose of the
Publikováno v:
The Cochrane Library
Background This is an updated version of the original Cochrane review published in 2014, Issue 4. Cervical intraepithelial neoplasia (CIN) precedes the development of invasive carcinoma of the cervix. Current treatment of CIN is quite effective, but
Autor:
Guy N. Brock, C. William Helm, Teresa W.-M. Fan, Clarisse S. Muenyi, Allan R. Pinhas, J. Christopher States
Publikováno v:
Toxicological Sciences. 127:139-149
Epithelial ovarian cancer (EOC) is the leading cause of gynecological cancer death in the United States. Cisplatin is a DNA damaging agent initially effective against EOC but limited by resistance. P53 plays a critical role in cellular response to DN
Autor:
C William Helm
Publikováno v:
Bjog
Objective To compare the recurrence rates after complete response to topical treatment with either cidofovir or imiquimod for vulval intraepithelial neoplasia (VIN) 3. Design A prospective, open, randomised multicentre trial. Setting 32 general hospi
Publikováno v:
Journal of Surgical Oncology. 98:283-290
Women with epithelial ovarian cancer (EOC) usually present with advanced disease and overall only just over half survive 5 years. Even following a complete response to front-line treatment two-thirds will recur, with a resultant dismal prognosis. We
Autor:
C. William Helm, Weon-Ju Jung, John Pappas, Enkhtuya Purev, Ralph S. Freedman, Maria Radu, John E. Fincke, Enrique Hernandez, Wan L. Lin, Chris D. Platsoucas, Angeliki K. Barda, John P. Gaughan
Publikováno v:
Cellular Immunology. 234:81-101
To determine whether clonally expanded T cells are present in tumor specimens from patients with epithelial ovarian carcinoma (EOC) we amplified by the non-palindromic adaptor PCR (NPA-PCR) or by Vbeta-specific PCR beta-chain T-cell receptor (TCR) tr
Autor:
C. William Helm, Alvin W. Martin, Sheron C. Lear, Grace D. Moore, James W. Snyder, Lisa A. Wills-Frank
Publikováno v:
Diagnostic Cytopathology. 32:82-87
Our objective was to correlate p16, p21cip1, p27kip1, and cyclin E protein expression with the degree of dysplasia on ThinPrep Papanicolaou (Pap) smears using a modified immunoperoxidase staining. Smears read as normal, atypical squamous cells of und